Additionally, although the total anti‐GPI antibody levels were similar in SM and MM patients, interestingly there was a clear correlation between surviving SM cases compared to SM cases with fatal outcomes; that is, the anti‐GPI antibody levels were significantly higher in the surviving SM group than SM group who died. Here, GPI is linked to systemic mastocytosis.